201. Comparative Quantification of Plasma hnRNP B1 mRNA in Non-small Cell Lung Cancer Patients by Real-time PCR
- Author
-
Sang-Hyun Hwang, Min Ki Lee, Yeong Dae Kim, Chulhun L. Chang, Eun Yup Lee, Sang Yull Lee, Jeong Man Kim, Chang Hun Lee, and Eun-Ju Song
- Subjects
Adult ,Lung Diseases ,Male ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Heterogeneous nuclear ribonucleoprotein ,Clinical Biochemistry ,Biology ,Polymerase Chain Reaction ,Carcinoma, Non-Small-Cell Lung ,Heterogeneous-Nuclear Ribonucleoprotein Group A-B ,Gene expression ,Biomarkers, Tumor ,medicine ,Carcinoma ,TaqMan ,Humans ,RNA, Messenger ,Lung cancer ,Aged ,Messenger RNA ,Lung ,Biochemistry (medical) ,General Medicine ,Middle Aged ,medicine.disease ,respiratory tract diseases ,medicine.anatomical_structure ,Real-time polymerase chain reaction ,Female - Abstract
BACKGROUND: Circulating cell-free nucleic acids are known to be a noninvasive diagnostic tool for cancer detection. Heterogeneous nuclear ribonucleoprotein (hnRNP) B1, a nuclear core complex, is overexpressed in early stage lung cancer. We intended to evaluate the usefulness of plasma hnRNP B1 mRNA in differentiating non-small cell lung cancer (NSCLC) from other benign lung diseases, especially pulmonary tuberculosis, which is highly prevalent in Korea and often difficult to distinguish from lung cancer. METHODS: Plasma RNA was extracted from 30 patients with NSCLC, 30 patients with benign lung diseases including pulmonary tuberculosis, and 10 healthy controls. Plasma hnRNP B1 mRNA was measured by TaqMan Gene Expression Assay (Applied Biosystems, USA), and pre-developed beta-actin (ACTB) mRNA was used for normalization. We analyzed the relative gene expression data using the delta-delta Ct method. RESULTS: Plasma hnRPN B1 mRNA was measurable in 93.3% (28/30) of NSCLC patients. Normalized 2-DeltaDeltaCt of plasma hnRPN B1 mRNA was 62.2 (95%Cl, 6.4-210.1) in NSCLC patients and 2.7 (95%Cl, 0.5-13.6) in benign lung disease patients (P
- Published
- 2009